VIRGINIA COMMONWEALTH UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1838-01-01

Employees: 10K

Market Cap: -

Website: http://www.vcu.edu

Clinical Trials

Study of a Structured Parent Intervention on Adolescent Weight Loss Modification Program.

Not Applicable

Completed

Conditions: Pediatric Obesity
Impact of Parent Intervention on Adolescent Weight Loss

Interventions: Behavioral: Lifestyle Intervention
Behavioral: Parent Motivational Interviewing

First Posted Date: 2014-03-13

Last Posted Date: 2016-02-11

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 110

Registration Number: NCT02086851

Locations: 🇺🇸
CHoR at VCU Healthy Lifestyles Center, Henrico, Virginia, United States

Brain Function and Structure in Cocaine Dependence

Phase 2

Completed

Conditions: Cocaine Dependence

Interventions: Drug: Placebo
Drug: Citalopram

First Posted Date: 2014-03-06

Last Posted Date: 2017-12-26

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 54

Registration Number: NCT02080832

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

Striatal Effective Connectivity to Predict Treatment Response in Cocaine Misuse

Phase 2

Completed

Conditions: Cocaine Dependence

Interventions: Drug: levodopa/carbidopa 400/100 BID

First Posted Date: 2014-03-06

Last Posted Date: 2018-04-12

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 131

Registration Number: NCT02080819

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

Development of Novel Cystometrics for Overactive Bladder

Active, not recruiting

Conditions: Urinary Frequency/Urgency

First Posted Date: 2014-02-11

Last Posted Date: 2024-10-08

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 104

Registration Number: NCT02060214

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

Diffusion-weighted MRI for Individualized Radiation Therapy Planning of Lung Cancer

Not Applicable

Withdrawn

Conditions: Recurrent Non-small Cell Lung Cancer
Stage IIA Non-small Cell Lung Cancer
Stage IIIA Non-small Cell Lung Cancer
Stage IIIB Non-small Cell Lung Cancer
Stage IIB Non-small Cell Lung Cancer

Interventions: Device: diffusion-weighted magnetic resonance imaging
Device: 4-dimensional computed tomography
Radiation: fludeoxyglucose F 18
Device: FDG-PET

First Posted Date: 2014-02-11

Last Posted Date: 2016-12-16

Lead Sponsor: Virginia Commonwealth University

Registration Number: NCT02059889

Locations: 🇺🇸
Virginia Commonwealth University Massey Cancer Center, Richmond, Virginia, United States

Phase I IGART Study Using Active Breathing Control and Simultaneous Boost for Patients With NSCLC

Phase 1

Withdrawn

Conditions: Stage IIB Non-small Cell Lung Cancer
Stage IIIA Non-small Cell Lung Cancer
Stage IIIB Non-small Cell Lung Cancer
Large Cell Lung Cancer
Stage IIA Non-small Cell Lung Cancer
Adenocarcinoma of the Lung
Squamous Cell Lung Cancer

Interventions: Drug: Paclitaxel
Radiation: image-guided adaptive radiation therapy
Drug: carboplatin

First Posted Date: 2014-02-11

Last Posted Date: 2015-03-19

Lead Sponsor: Virginia Commonwealth University

Registration Number: NCT02059967

Point of Care (POC) Biomarkers of Ischemia

Completed

Conditions: Acute Coronary Syndrome
Myocardial Infarction

First Posted Date: 2014-01-20

Last Posted Date: 2019-09-13

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 85

Registration Number: NCT02039882

Locations: 🇺🇸
Virginia Commonwealtlh University Health Systems, Richmond, Virginia, United States

Confocal Endomicroscopy for Non-Erosive Reflux Disease (CE NERD)

Not Applicable

Withdrawn

Conditions: Non Erosive Reflux Disease
Gastroesophageal Reflux Disease
Dyspepsia

Interventions: Device: Confocal endomicroscopy
Drug: Proton pump inhibitor
Drug: Sucralfate

First Posted Date: 2014-01-20

Last Posted Date: 2015-12-09

Lead Sponsor: Virginia Commonwealth University

Registration Number: NCT02039869

Locations: 🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States
🇺🇸
Ochsner Medical Center, Kenner, Louisiana, United States
🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

The Management of Resistant Hypertension in Kidney Transplant Patients Using Chlorthalidone

Phase 4

Withdrawn

Conditions: Resistant Hypertension in Kidney Transplant Patients

Interventions: Drug: Chlorthalidone

First Posted Date: 2014-01-08

Last Posted Date: 2017-06-15

Lead Sponsor: Virginia Commonwealth University

Registration Number: NCT02030314

Locations: 🇺🇸
Virginia Commonwealtlh University, Richmond, Virginia, United States

Developing an Online Clinical Trial Specific Question Prompt List

Not Applicable

Terminated

Conditions: Cancer

Interventions: Behavioral: QPL-CT

First Posted Date: 2014-01-08

Last Posted Date: 2015-07-07

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 8

Registration Number: NCT02030379

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy